New developments in immunotherapy for SCLC

Small cell lung cancer (SCLC) is an aggressive form of neuroendocrine neoplasm known for its striking initial response to treatment, followed by fast relapse and refractoriness in response to additional lines of therapy. New advances in immunotherapy are paving the way for more effective treatment s...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhonglin Hao, Tsering Dolkar, Christopher Gates, Reinhold Munker
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/1/e009667.full
Tags: Add Tag
No Tags, Be the first to tag this record!